(Thr4,Gly7)-Oxytocin is a modified oxytocin analog featuring threonine and glycine substitutions that influence receptor interaction and peptide stability. These changes alter the peptide's hydrophobicity and flexibility, providing insights into receptor-specific binding. The modified oxytocin retains its ability to stimulate uterine contractions, making it useful for exploring receptor subtype interactions. Researchers apply it in studies of peptide hormone signaling.
CAT No: O06001
Synonyms/Alias:(Thr4,Gly7)-Oxytocin;60786-59-6;Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2;MFCD00076735;Thr4-Gly7-Oxytocin;[Thr...4...,Gly...7...]OT;CHEMBL3249214;HY-P3467;DA-59716;CS-0609562;Glycinamide,l-cysteinyl-L-tyrosyl-L-isoleucyl-L-threonyl-L-asparaginyl-L-cysteinylglycyl-L-leucyl-,cyclic(1(R)6)-disulfide;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More